Home » Topics » BioWorld Science

BioWorld Science
RSS

Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease

June 27, 2022

Tokyo University of Science discloses LXR antagonists

June 27, 2022

Merck & Co. identifies new GLCT-1 inhibitors

June 27, 2022

SAGE Therapeutics describes new GABA-A receptor modulators

June 27, 2022

Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer

June 27, 2022

Sumitomo Pharma divulges Chk1 inhibitors

June 27, 2022

Servier patents new MAT2A inhibitors

June 27, 2022

Novel murine model may shed light for future strategies for aggressive glioblastoma

June 27, 2022

Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines

June 27, 2022

Inhibitor harms leukemic stem cells while boosting normal ones

June 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026